Pendrell Corporation acquired 68.75% stake in Provitro Biosciences LLC for $16.6 million.
Pendrell Corporation (NasdaqGS:PCO) completed the acquisition of 68.75% stake in Provitro Biosciences LLC on February 21, 2013.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,50,000 USD | -.--% | -.--% | -.--% |
1st Jan change | Capi. | |
---|---|---|
-.--% | 14Cr | |
+6.81% | 42Cr | |
+90.00% | 17Cr | |
-14.50% | 14Cr | |
+143.86% | 9.6Cr | |
+19.37% | 8.97Cr | |
+84.16% | 6.23Cr |